BUFFALO, N.Y., – May 7, 2026 – Ognomy Sleep, a virtual-first care platform redefining the diagnosis and treatment of obstructive sleep apnea (OSA), today announced it has been named “Best Overall SleepTech Solution” in the 10th annual MedTech Breakthrough Awards program. The awards, conducted by MedTech Breakthrough—an independent market intelligence organization—recognize the most innovative companies and technologies shaping the future of global healthcare.
Ognomy Sleep delivers a fully virtual, end-to-end care model for OSA, enabling patients to complete evaluation, home sleep testing, diagnosis, and treatment entirely from home. By combining specialist-led care with a seamless digital experience, the platform removes traditional barriers to access and dramatically accelerates time to diagnosis and optimal therapy.
Patients can engage with care through web and mobile interfaces, while integrated wearable data—such as from the Oura® Ring—provides clinicians with continuous, real-world insights to personalize treatment and improve outcomes.
Ognomy also offers OgnomyFit™, a digitally delivered lifestyle intervention program designed to address both sleep apnea and obesity. By targeting the interconnected drivers of sleep fragmentation, metabolic dysfunction, and weight gain, the program empowers patients and equips clinicians with actionable data to optimize long-term care.
“Addressing sleep apnea has never been more urgent,” said Dr. Daniel Rifkin, President and CEO of Ognomy Sleep. “Traditional sleep care is fragmented and slow, often requiring months to access care. Our model compresses that timeline into days—removing geographic and logistical barriers while improving adherence and outcomes. We’re honored to receive this recognition and remain committed to expanding access to high-quality, longitudinal sleep care.”
Now in its 10th year, the MedTech Breakthrough Awards program highlights organizations driving meaningful progress across the healthcare landscape, spanning categories such as telehealth, patient engagement, virtual care, and medical devices. This year’s program received a record number of nominations from companies across more than 20 countries.
“The Ognomy platform stands out for its combination of clinical rigor and flexibility in treatment,” said Steve Johansson, Managing Director of MedTech Breakthrough. “With over 50 million U.S. adults affected by OSA—and an estimated 80% undiagnosed—there is a critical need for scalable solutions. By virtualizing the entire care pathway, Ognomy significantly reduces time to diagnosis and intervention, delivering care when it matters most.”
To date, Ognomy Sleep has completed more than 65,000 virtual visits and treated over 25,000 patients nationwide, operating across all 50 states.
About Ognomy Inc.
Ognomy Inc., also known as Ognomy Sleep, is a virtual care platform specializing in the diagnosis and treatment of obstructive sleep apnea (OSA). By integrating clinical expertise with advanced technology and automation, Ognomy delivers a streamlined, end-to-end patient journey—from initial evaluation through long-term management. With nationwide coverage and expanding in-network insurance partnerships, Ognomy is advancing access to high-quality sleep care while addressing the broader cardiometabolic impact of untreated OSA. Learn more at www.ognomy.com.
About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation, the MedTech Breakthrough Awards program honors excellence across the healthcare technology ecosystem. Categories include patient engagement, connected healthcare, medical devices, clinical administration, and more. For more information, visit MedTechBreakthrough.com. Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.
